1. Home
  2. STOK vs MBUU Comparison

STOK vs MBUU Comparison

Compare STOK & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • MBUU
  • Stock Information
  • Founded
  • STOK 2014
  • MBUU 1982
  • Country
  • STOK United States
  • MBUU United States
  • Employees
  • STOK N/A
  • MBUU N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • MBUU Marine Transportation
  • Sector
  • STOK Health Care
  • MBUU Industrials
  • Exchange
  • STOK Nasdaq
  • MBUU Nasdaq
  • Market Cap
  • STOK 517.0M
  • MBUU 582.6M
  • IPO Year
  • STOK 2019
  • MBUU 2014
  • Fundamental
  • Price
  • STOK $9.36
  • MBUU $29.35
  • Analyst Decision
  • STOK Strong Buy
  • MBUU Hold
  • Analyst Count
  • STOK 5
  • MBUU 6
  • Target Price
  • STOK $27.50
  • MBUU $36.80
  • AVG Volume (30 Days)
  • STOK 813.9K
  • MBUU 218.6K
  • Earning Date
  • STOK 05-20-2025
  • MBUU 05-08-2025
  • Dividend Yield
  • STOK N/A
  • MBUU N/A
  • EPS Growth
  • STOK N/A
  • MBUU N/A
  • EPS
  • STOK N/A
  • MBUU N/A
  • Revenue
  • STOK $36,555,000.00
  • MBUU $759,234,000.00
  • Revenue This Year
  • STOK $27.80
  • MBUU N/A
  • Revenue Next Year
  • STOK $9.53
  • MBUU $11.48
  • P/E Ratio
  • STOK N/A
  • MBUU N/A
  • Revenue Growth
  • STOK 316.34
  • MBUU N/A
  • 52 Week Low
  • STOK $5.35
  • MBUU $24.43
  • 52 Week High
  • STOK $17.58
  • MBUU $47.82
  • Technical
  • Relative Strength Index (RSI)
  • STOK 57.94
  • MBUU 51.08
  • Support Level
  • STOK $8.30
  • MBUU $28.11
  • Resistance Level
  • STOK $10.12
  • MBUU $31.11
  • Average True Range (ATR)
  • STOK 0.59
  • MBUU 1.15
  • MACD
  • STOK -0.03
  • MBUU 0.32
  • Stochastic Oscillator
  • STOK 58.24
  • MBUU 57.79

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About MBUU Malibu Boats Inc.

Malibu Boats is a leading designer and manufacturer of power boats in the United States. It is the market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a leading producer of sterndrive boats in the us in the 24- to 29-foot segment, in 2017 and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a leading seller of flat fishing boats, including bay, dual-console, and center-console boats. Malibu has also expanded into boat trailers and accessories and in 2020 began producing its own engines (Monsoon) for its performance sport boats and now for Cobalt. Malibu's target market includes a wide range of water enthusiasts who embrace the active outdoor lifestyle.

Share on Social Networks: